DEPO DepoMed Inc.

DEPO SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Depomed, Inc.

NEW YORK--(BUSINESS WIRE)--

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Depomed, Inc. (“Depomed”) (NASDAQ: DEPO) violated federal securities laws.

Click here to learn about the case: http://docs.wongesq.com/DEPO-Request-Form-1683. There is no cost or obligation to you.

On August 7, 2017, Depomed announced that it had received a request for information relating to the promotion of opioids from the U.S. Senate Committee on Homeland Security and Governmental Affairs as well as the Office of the Attorney General of Maryland and the U.S. Department of Justice.

To learn more about the investigation of Depomed contact Vincent Wong, Esq. either via email [email protected], by telephone at 212.425.1140, or visit http://docs.wongesq.com/DEPO-Request-Form-1683.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
22/08/2017

Underlying

DEPODepoMed Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DepoMed Inc.

 PRESS RELEASE
Free
DEPO DEPOMED INC.

Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics,...

Depomed Inc. Announces Corporate Name Change to Assertio Therapeutics, Inc. Name Change Reflects Company’s Focus on Neurology, Orphan and Specialty Businesses LAKE FOREST, Ill., Aug. 15, 2018 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ: ASRT), a leading specialty pharmaceutical company committed to advancing patient care, has announced that its corporate name change from “Depomed, Inc.” to “Assertio Therapeutics, Inc.” became effective at 11:59 p.m. ET yesterday, August 14, 2018. In connection with the name change, the Company’s common stock will begin trading under a new ti...

August 15, 2018 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
PAG PENSKE AUTOMOTI...
VER VEREIT INC. ... (+40)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

PAG PENSKE AUTOMOTIVE GROUP INC
VER VEREIT INC.
ATNI ATN INTERNATIONAL INC.
TBPH THERAVANCE BIOPHARMA INC
SUP SUPERIOR INDUSTRIES INTERNATIONAL INC.
SSYS STRATASYS LTD.
SNF DIVERSIFIED HEALTHCARE TRUST
SRN SPRINT CORP.
PAA PLAINS ALL AMERICAN PIPELINE L.P.
OFC CORPORATE OFFICE PROPERTIES TRUST
NUVA NUVASIVE INC.
NTRI NUTRISYSTEM INC.
MRCY MERCURY SYSTEMS INC.
LQDT LIQUIDITY SERVICES
LB7 LIBBEY INC.
KMB KIMBERLY-CLARK CORPORATION
HTA HEALTHCARE TRUST OF AMERICA INC. CLASS A
HR HEALTHCARE REALTY TRUST INCORPORATED
HCP HEALTHPEAK PROPERTIES INC.
DORM DORMAN PRODUCTS INC.
DOC PHYSICIANS REALTY TRUST
DKS DICK'S SPORTING GOODS INC.
DEPO DEPOMED INC.
CLFD CLEARFIELD INC.
CHRS COHERUS BIOSCIENCES INC.
A2AM8Y CARDTRONICS PLC CLASS A
BXP BOSTON PROPERTIES INC.
BRX BRIXMOR PROPERTY GROUP INC.
APOG APOGEE ENTERPRISES INC.
APA.. APA CORP.
ANDE ANDERSONS INC.
DRQ DRIL-QUIP INC.
FI FRANK'S INTERNATIONAL NV
KMI KINDER MORGAN INC CLASS P
VSI VITAMIN SHOPPE
TYIA JOHNSON CONTROLS INTERNATIONAL PLC
HWKN HAWKINS INC.
BELFB BEL FUSE INC. CL B
CLPR CLIPPER REALTY
EXPRESS TRANSPORT S.A.
08/08/18 August 8, 2018 24 EN
 PRESS RELEASE
Free
DEPO DEPOMED INC.

Depomed Announces Second-Quarter 2018 Financial Results

Depomed Announces Second-Quarter 2018 Financial Results -- Raises Full-Year Earnings and Adjusted EBITDA Guidance Range and Lowers Full-Year Net Sales Guidance Range for the Neurology Franchise -- -- Confirms Regulatory Plan to File for FDA Approval of Cosyntropin Depot by Year End -- -- Announces Agreement with PDL BioPharma to Monetize Royalty Stream; Company Received $20 Million in Cash -- -- Announces Planned Change in Company Name from Depomed to Assertio Therapeutics;Remains On-Track to Transition to New Corporate Headquarters in Lake Forest, Illinois -- LAKE FOREST, Ill., Aug. 0...

August 8, 2018 1 EN
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke
HABT The Habit Resta...
TTSH Tile Shop Holdi... ... (+25)

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

HABT THE HABIT RESTAURANTS
TTSH TILE SHOP HOLDINGS INC.
SCG SCANA CORPORATION
REGN REGENERON PHARMACEUTICALS INC.
O REALTY INCOME CORPORATION
NTCT NETSCOUT SYSTEMS INC.
LQDT LIQUIDITY SERVICES
LOCO EL POLLO LOCO HOLDINGS INC
KN KNOWLES CORP.
K KELLOGG COMPANY
HSIC HENRY SCHEIN INC.
GPC GENUINE PARTS COMPANY
DEPO DEPOMED INC.
CHRS COHERUS BIOSCIENCES INC.
BRX BRIXMOR PROPERTY GROUP INC.
APA.. APA CORP.
AGNN ALLERGAN PLC
AGO ASSURED GUARANTY LTD.
FI FRANK'S INTERNATIONAL NV
MAT MATTEL INC.
TCO TAUBMAN CENTERS INC.
WMB WILLIAMS COMPANIES INC.
DFIN DONNELLEY FINANCIAL SOLUTIONS INC.
HWKN HAWKINS INC.
SVU SUPERVALU INC.
07/25/18 July 25, 2018 15 EN
 PRESS RELEASE
Free
DEPO DEPOMED INC.

Depomed to Report Second-Quarter 2018 Financial Results on Wednesday, ...

Depomed to Report Second-Quarter 2018 Financial Results on Wednesday, August 8, 2018 LAKE FOREST, Ill., July 09, 2018 (GLOBE NEWSWIRE) -- Depomed, Inc. (NASDAQ:DEPO) today announced that it will release second-quarter 2018 financial results on Wednesday, August 8, 2018, before the open of markets. Following the announcement, the Company will host a conference call beginning at 8:30 a.m. ET to discuss its results. Participants can access the live webcast from the Investor Relations section of Depomed's website at . Please access the website 15 minutes prior to the start of the call to dow...

July 9, 2018 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch